Gestational diabetes in Iran: incidence, risk factors and pregnancy outcomes

被引:124
作者
Keshavarz, M
Cheung, NW
Babaee, GR
Moghadam, HK
Ajami, ME
Shariati, M
机构
[1] Shahroud Fac Med Sci & Hlth Sci, Dept Ob & Gyn, Shahroud, Iran
[2] Westmead Hosp, Ctr Diabet & Endocrinol Res, Westmead, NSW, Australia
[3] Tarbiat Modares Univ, Dept Biostat, Tehran, Iran
[4] Shahroud Fac Med Sci & Hlth Serv, Res Dept, Shahroud, Iran
[5] Iranian Inst Hlth Sci Res, Tehran, Iran
关键词
gestational diabetes mellitus; incidence; risk factors; outcomes;
D O I
10.1016/j.diabres.2005.01.011
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The objective of this study was to determine the incidence of gestational diabetes mellitus (GDM) and compare fetal, maternal and neonatal complications amongst women with GDM and pregnant women with normal glucose tolerance in an urban Iranian population. In a prospective cohort study, universal screening for gestational diabetes mellitus was performed for 13 10 pregnant women who were referred from private clinics and community health care centers to Fatemiyeh Hospital in Shahrood City. Screening was performed with a 50 g oral Glucose Challenge Test (GCT) with 130 mg/dI cut-off point, then a diagnostic 100 g Oral Glucose Tolerance Test (OGTT) was done according to Carpenter and Coustan criteria. The incidence of GDM was 4.8%. There were differences in risk factors: age > 30 years, family history of diabetes, obesity, previous macrosomia, glycosuria between the two groups (P < 0.001). Women with GDM had a higher rate of stillbirth (P < 0.001; odds ratio 17.1, 95% CI = 4.5-65.5), hydramnios (P < 0.001; odds ratio 15.5, 95% CI = 4.8-50.5), gestational hypertension (P < 0.001; odds ratio 6, 95% CI = 2.3-15.3), macrosomia (P < 0.05; odds ratio 3.2, 95% CI = 1.2-8.6) and caesarean section (P < 0.001). We have found that the incidence of GDM in an urban Iranian population is similar to developed countries. Complications were more common in the GDM group than in the normal group and outcomes for women with persistent diabetes post-parturn were particularly poor. We recommend screening for GDM in Iran, but further evaluation of selective screening and cost effectiveness will need to be performed. Measures to improve the outcome of GDM pregnancy will also need to be addressed in the future. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 38 条
[1]
Akhter J, 1996, DIABETIC MED, V13, P189, DOI 10.1002/(SICI)1096-9136(199602)13:2<189::AID-DIA32>3.0.CO
[2]
2-4
[3]
American Diabetes Association, 2003, DIABETES CARE, V26, P33
[4]
American Diabetes Association, 2002, DIABETES CARE, V25, P94
[5]
[Anonymous], 2004, Diabetes Care, V27, P88, DOI [DOI 10.2337/DIACARE.27.2007.S88, 10.2337/diacare.27.2007.S88]
[6]
Bartha JL, 2001, AM J OBSTET GYNECOL, V184, P247, DOI 10.1067/mob.2001.108986
[7]
PANCREATIC DISORDERS OF PREGNANCY - DIAGNOSIS, MANAGEMENT, AND OUTCOME OF GESTATIONAL DIABETES [J].
BEVIER, WC ;
JOVANOVICPETERSON, L ;
PETERSON, CM .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1995, 24 (01) :103-138
[8]
CRITERIA FOR SCREENING-TESTS FOR GESTATIONAL DIABETES [J].
CARPENTER, MW ;
COUSTAN, DR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 144 (07) :768-773
[9]
Risk factors for gestational diabetes among Asian women [J].
Cheung, NW ;
Wasmer, G ;
Al-Ali, J .
DIABETES CARE, 2001, 24 (05) :955-956
[10]
COUNNNINGHAM FG, 2001, WILLIAMS OBSTET, P1361